Thinking about trading options or stock in Northrop Grumman, Occidental Petroleum, Progressive, Johnson & Johnson, or Apple?

Virios Therapeutics Inc

Change company Symbol lookup

Select an option...

VIRI Virios Therapeutics Inc

TCBS Texas Community Bancshares Inc

UPC Universe Pharmaceuticals Inc

MHH Mastech Digital Inc

GCTK GlucoTrack Inc

KODK Eastman Kodak Co

FYBR Frontier Communications Parent Inc

TPNEF Cub Energy Inc

ECC Eagle Point Credit Co LLC

CPHI China Pharma Holdings Inc

Health Care : Biotechnology |

Company profile

Virios Therapeutics, Inc., formerly Virios Therapeutics, LLC., is a development-stage biotechnology company focused on advancing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM). Its lead development candidate is IMC-1, which is a fixed dose combination of famciclovir and celecoxib. IMC-1 represents a combination antiviral therapy designed to synergistically suppress Herpes Simplex Virus-1 (HSV-1) activation and replication. Its HSV-1 root cause of chronic illnesses such as FM, irritable bowel disease (IBS), chronic fatigue syndrome and functional somatic syndrome. The Company is developing its initial candidate, IMC-1, for people who are suffering from fibromyalgia.

Thinking about trading options or stock in Northrop Grumman, Occidental Petroleum, Progressive, Johnson & Johnson, or Apple?

9:31 am ET July 1, 2022 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for NOC, OXY, PGR, JNJ, and AAPL.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- NOC: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=NOC&prnumber=070120224

-- OXY: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=OXY&prnumber=070120224

-- PGR: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=PGR&prnumber=070120224

-- JNJ: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=JNJ&prnumber=070120224

-- AAPL: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=AAPL&prnumber=070120224

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG06938&sd=2022-07-01

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-northrop-grumman-occidental-petroleum-progressive-johnson--johnson-or-apple-301579680.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG06938&Transmission_Id=202207010931PR_NEWS_USPR_____CG06938&DateId=20220701

COMTEX_409530542/1005/2022-07-01T09:31:09